Correlation Between NervGen Pharma and Arch Biopartners

Can any of the company-specific risk be diversified away by investing in both NervGen Pharma and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NervGen Pharma and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NervGen Pharma Corp and Arch Biopartners, you can compare the effects of market volatilities on NervGen Pharma and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NervGen Pharma with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of NervGen Pharma and Arch Biopartners.

Diversification Opportunities for NervGen Pharma and Arch Biopartners

-0.63

Correlation Coefficient

NervGen Pharma  Arch Biopartners

Excellent diversification

The 3 months correlation between NervGen and Arch is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding NervGen Pharma Corp and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and NervGen Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NervGen Pharma Corp are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of NervGen Pharma i.e., NervGen Pharma and Arch Biopartners go up and down completely randomly.

Pair Corralation between NervGen Pharma and Arch Biopartners

Assuming the 90 days horizon NervGen Pharma is expected to generate 3.66 times less return on investment than Arch Biopartners. In addition to that, NervGen Pharma is 1.79 times more volatile than Arch Biopartners. It trades about 0.03 of its total potential returns per unit of risk. Arch Biopartners is currently generating about 0.19 per unit of volatility. If you would invest  145.00  in Arch Biopartners on September 4, 2024 and sell it today you would earn a total of  51.00  from holding Arch Biopartners or generate 35.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

NervGen Pharma Corp  vs.  Arch Biopartners

NervGen Pharma Corp

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NervGen Pharma Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, NervGen Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Arch Biopartners

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Arch Biopartners are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal fundamental indicators, Arch Biopartners showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NervGen Pharma and Arch Biopartners

The main advantage of trading using opposite NervGen Pharma and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NervGen Pharma position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.

The idea behind NervGen Pharma Corp and Arch Biopartners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.